(Q48658942)

14 February 2018

editorial

0 references

title

What benefits could caloric restriction bring to cancer patients? (English)

1 reference

14 February 2018

1 reference

Tu D Dan

1

1 reference

14 February 2018

Christopher M Wright

series ordinal

2

1 reference

14 February 2018

Nicole L Simone

series ordinal

3

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 December 2014

1 reference

14 February 2018

published in

Future Oncology

1 reference

14 February 2018

volume

10

1 reference

14 February 2018

issue

16

1 reference

14 February 2018

page(s)

2543-2546

1 reference

14 February 2018

Oxidative stress, caloric restriction, and aging

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.241

Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.241

Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.241

Obesity and cancer risk: the role of the insulin-IGF axis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.241

Energy restriction and the risk of spontaneous mammary tumors in mice: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.241

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.241

Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.241

Caloric restriction augments radiation efficacy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.241

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.241

Fasting and differential chemotherapy protection in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.241

Weight, weight gain, and survival after breast cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.241

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.241

Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.241

Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.241

Obesity and breast cancer: status of leptin and adiponectin in pathological processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.241

21 January 2018

Identifiers

DOI

10.2217/FON.14.241

1 reference

14 February 2018

1 reference

14 February 2018